AUREOMYCIN- chlortetracycline hydrochloride granule 
Zoetis Inc.

----------

Aureomycin® 50 Granular A

Aureomycin®

50 Granular A

Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Chlortetracycline
Type A Medicated Article

Active drug ingredient

Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.

Ingredients

Aureomycin Granular Type A Medicated Article (Dried Streptomyces aureofaciens Fermentation Product and Calcium Sulfate) and Calcium Carbonate.

For use in the manufacture of medicated animal feeds.
For use in dry feed only. Not for use in liquid medicated feeds.

Use directions

Mix sufficient Aureomycin 50 Granular A Medicated Article to supply desired concentration of chlortetracycline per ton with part of the feed ingredients to make a preblend.
Add the remainder of the ingredients and mix thoroughly. For specific use levels, see Indications for use.

Mixing directions

Level desired
grams per ton
Amount of medicated article per ton †
 10 1/5 lb
 50 1 lb
 100 2 lb
 200 4 lb
 400 8 lb
 500 10 lb

† It is recommended that 1 pound of Aureomycin 50 Granular A Type A Medicated Article be diluted with 4 pounds of one of the feed ingredients to form a 5 pound working premix. Use 1 pound of the working premix to make a preblend (see Use directions) for a Type C feed containing 10 g Aureomycin chlortetracycline / ton of feed.

Indications for use

Indications for use Chlortetracycline
mg per lb body
wt per day
Cattle 
    
Beef Cattle (over 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. 0.5
    
Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline when delivered in a free-choice feed. Free-choice feed must be manufactured under a feed mill license utilizing an FDA approved formulation. 0.5-2.0
    
Calves, Beef and Non-Lactating Dairy Cattle: Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline. Feed for not more than 5 days. The appropriate amount of Aureomycin-containing feed supplement may be mixed in the cattle's daily ration or administered as a top-dress. If the Aureomycin-containing feed supplement is administered as a top-dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time. 10
  
Swine 
Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline.
Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: this drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight.)
Feed for not more than 14 days.
 10
  
Turkeys 
Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis; coronaviral enteritis) susceptible to chlortetracycline. Feed continuously for 7 to 14 days. 25
  
Indications for use mg per head
per day
Cattle 
Growing Cattle (over 400 lb): Increased rate of weight gain, improved feed efficiency, and reduction of liver condemnation due to liver abscesses. 70
    
Beef Cattle and Dairy Replacement Heifers: Control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline. 350
    
Beef Cattle (under 700 lb): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. 350
  
Sheep 
Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline. 80
  
Indications for use In complete feed Chlortetracycline g per ton
Swine 
Reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. 50-100
    
Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. Feed continuously for not more than 14 days. 400
 
Ducks 
Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline. Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending upon age and severity of disease. Feed for not more than 21 days. 200-400
  
Chickens 
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Feed continuously for 7 to 14 days.
 100-200
    
Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline.
Feed continuously for 7 to 14 days.
 200-400
    
Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline. Feed for 5 days. 500
  
Turkeys 
Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Feed continuously for 7 to 14 days.
 200
    
Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline.
Feed continuously for 7 to 14 days.
 400
    
Turkey Poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline. 400
  
Indications for use mg per g feed
Psittacine birds 
Warning: Psittacosis, avian chlamydiosis, or ornithosis is a reportable communicable disease, transmissible between wild and domestic birds, other animals and man. Contact appropriate public health and regulatory officials. 
Caution: Aspergilliosis may occur following prolonged treatment. 
    
Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline. Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of its body weight daily. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages. 10

Withdrawal Periods and Residue Warnings

No withdrawal period is required when used according to labeling. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys producing eggs for human consumption.

NO TITLE

Store below 25°C (77°F), excursions permitted to 37°C (99°F)
Restricted Drug (California) - Use only as directed. Not for use in humans. Keep out of reach of children.
Approved by FDA under NADA # 048-761

 

zoetis

Distributed by:
Zoetis Inc.
Kalamazoo, MI 49007

40025762

PRINCIPAL DISPLAY PANEL

50 Granular A bag label
AUREOMYCIN 
chlortetracycline hydrochloride granule
Product Information
Product TypeVFD TYPE A MEDICATED ARTICLE ANIMAL DRUGItem Code (Source)NDC:54771-1002
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORTETRACYCLINE HYDROCHLORIDE (UNII: O1GX33ON8R) (CHLORTETRACYCLINE - UNII:WCK1KIQ23Q) CHLORTETRACYCLINE HYDROCHLORIDE50 g  in 0.45 kg
Inactive Ingredients
Ingredient NameStrength
CALCIUM CARBONATE (UNII: H0G9379FGK)  
CALCIUM SULFATE (UNII: WAT0DDB505)  
Product Characteristics
Colorgray (gray to brown) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54771-1002-022.68 kg in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NADANADA04876101/01/2009
Labeler - Zoetis Inc. (828851555)

Revised: 12/2022
Document Id: 2fec8cfd-c496-471a-a76a-c60ee32de573
Set id: 9b3b27c0-b584-438f-acee-44549f449c1b
Version: 5
Effective Time: 20221213
 
Zoetis Inc.